Table 4.
Comparison of the drug susceptibility testing results of BACTEC MGIT 960 and targeted capture sequencing.
| Sample number | BACTEC MGIT 960 | Targeted capture sequencing |
|---|---|---|
| 1 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 2 | STR, INH, RMP, EMB, CAP, AMK, OFX | CAP/STR/AMK/KAN (rrs:1473329); CAP/AMK/KAN (rrs:1473247) |
| 3 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 4 | STR, INH, RMP, EMB, CAP, AMK, OFX | CAP/AMK/KAN (rrs:1473247), CAP/STR/AMK/KAN (rrs:1473329) |
| 5 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 6 | STR, INH, RMP, EMB, CAP, AMK, OFX | INH (katG:2154724), EMB (embB:4248115) |
| 7 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 8 | STR, INH, RMP, CAP, AMK | – |
| 9 | STR, INH, RMP, CAP, AMK, OFX | – |
| 10 | – | – |
| 11 | – | – |
| 12 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 13 | – | – |
| 14 | – | – |
| 15 | STR, INH, RMP, EMB, CAP, AMK, OFX | CAP/AMK/KAN (rrs:1473247), CAP/STR/AMK/KAN (rrs:1473329) |
| 16 | – | |
| 17 | STR, INH, RMP, EMB, CAP, AMK, OFX | FLQ (gyrA:9304), RMP (rpoB:761155;763031), AMK/KAN (rrs:1473246), STR(rpsL:781687), PZA (pncA:2289016, rpsA:1834177), INH (katG:2155168), EMB (embC:4242643, embA:4243460, embB:4247429) |
| 18 | – | – |
| 19 | STR, INH, RMP, EMB | STR (rrs:1472307), CAP/KAN/AMK (rrs:1473247), CAP/KAN/AMK/STR (rrs:1473329) |
| 20 | STR, INH, RMP | – |
| 21 | STR, INH, RMP, EMB, CAP, AMK, OFX | FLQ (gyrA:9304), CAP/AMK/KAN (rrs:1473247) |
| 22 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 23 | STR, INH, RMP, EMB, CAP, AMK, OFX | – |
| 24 | INH, RMP | – |
| 25 | INH, EMB, CAP, AMK | STR (rrs:1472644) |
| 26 | – | FLQ (gyrA:7585;9304), RMP (rpoB:763031), STR (rpsL:781822) PZA (rpsA: 183417) |
| 27 | STR, INH, RMP, OFX | – |
| 28 | STR, INH, CAP, AMK, OFX | – |
| 29 | – | – |
| 30 | STR, INH, RMP, CAP, AMK, OFX | – |